(Q34841404)

4 August 2017

Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin (English)

1 reference

domain-ontology-based fuzzy-powered named-entity recognition matcher

4 August 2017

0 references

1 reference

1 reference

Pharmacology

5 February 2022

author name string

Kenneth C Cundy

1

1 reference

4 August 2017

Srikonda Sastry

2

1 reference

4 August 2017

Wendy Luo

3

1 reference

4 August 2017

Joan Zou

4

1 reference

4 August 2017

Tristen L Moors

5

1 reference

4 August 2017

Daniel M Canafax

6

1 reference

4 August 2017

30 September 2008

1 reference

The Journal of Clinical Pharmacology

4 August 2017

1 reference

4 August 2017

48

1 reference

4 August 2017

12

1 reference

4 August 2017

1378-1388

1 reference

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

4 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322909

Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322909

Gabapentin in the management of convulsive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322909

Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322909

Gabapentin as a potential treatment for anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322909

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322909

Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322909

XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322909

XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322909

A summary of mechanistic hypotheses of gabapentin pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322909

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322909

Failure of Absorption of Gabapentin After Rectal Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322909

21 January 2018

Identifiers

DOI

10.1177/0091270008322909

1 reference

4 August 2017

1 reference